Fort Dodge recalls ProHeart 6, citing FDA safety concerns
At the request of the Food and Drug Administration, Fort Dodge Animal Health voluntarily ceased production of ProHeart 6, and recalled all ProHeart 6 that had been distributed to veterinarians until the FDA's concerns about the drug's safety are resolved. [more]

DEA issues pain medication FAQ
The Drug Enforcement Administration has issued a frequently asked questions document to cover the clinical and regulatory issues surrounding the prescription of pain medication. [more]

FDA to revise Compliance Policy Guide on veterinary compounding
The Food and Drug Administration has announced its intention to draft and publish for public comment a revised Compliance Policy Guide on veterinary pharmaceutical compounding. [more]